Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

Martin Shkreli

View as an RSS Feed
View Martin Shkreli's Comments BY TICKER:
Latest  |  Highest rated
  • Oncothyreon: Phase III Unlikely to Show Survival Benefit [View article]
    Glad it worked out for you, redplate! :)
    Dec 20 07:35 AM | 0 Likes Like |Link to Comment
  • Oncothyreon: Phase III Unlikely to Show Survival Benefit [View article]
    Thanks!!
    Dec 20 07:33 AM | 0 Likes Like |Link to Comment
  • Debt Burden Makes Horizon Pharma An Attractive Short [View article]
    That's the idea. I would imagine they would do a secondary before they actually default, however.
    Jul 26 10:07 PM | 0 Likes Like |Link to Comment
  • Debt Burden Makes Horizon Pharma An Attractive Short [View article]
    Congrats. Hope you made money.
    Jul 26 05:00 PM | 1 Like Like |Link to Comment
  • Debt Burden Makes Horizon Pharma An Attractive Short [View article]
    Hi William,

    Thanks for your comments.

    Martin Shkreli
    Jul 26 02:58 PM | 1 Like Like |Link to Comment
  • Debt Burden Makes Horizon Pharma An Attractive Short [View article]
    I look at about 2000 global healthcare stocks and private companies. I sometimes am playing catch-up. Given the recent PDUFA I took some time to look at this. It's a great short.
    Jul 26 08:15 AM | 1 Like Like |Link to Comment
  • Debt Burden Makes Horizon Pharma An Attractive Short [View article]
    I'm glad your mother benefitted from this company's drug. I'm not sure how this is the case given their only product has been available briefly. Regarding your offer to lend to the company, I think they need about $100 million, so you might want to call the CFO.
    Jul 26 08:00 AM | 4 Likes Like |Link to Comment
  • Debt Burden Makes Horizon Pharma An Attractive Short [View article]
    I have recently learned about the company due to the impending PDUFA and rise in stock price. I felt it useful to voice my opinion given the large opportunity to make money on the coming decline in the stock price.
    Jul 26 07:59 AM | 3 Likes Like |Link to Comment
  • Debt Burden Makes Horizon Pharma An Attractive Short [View article]
    I value your opinion. If they get bought out, I will lose money. Also note that if I get hit by a car, I will be hurt. Also note if 1 + 1, then 2.
    Jul 26 07:58 AM | 9 Likes Like |Link to Comment
  • Debt Burden Makes Horizon Pharma An Attractive Short [View article]
    No. Thank you for your opinion.
    Jul 26 07:57 AM | 4 Likes Like |Link to Comment
  • Debt Burden Makes Horizon Pharma An Attractive Short [View article]
    There's no benefit or risk. I'm just telling you what I think. If you look at my track record, it is pretty darn good. I figure the "little guy" could use a pro's opinion.
    Jul 26 07:56 AM | 3 Likes Like |Link to Comment
  • Debt Burden Makes Horizon Pharma An Attractive Short [View article]
    lol best comments ever
    Jul 26 07:45 AM | 2 Likes Like |Link to Comment
  • Nektar Phase III Trials At Risk [View article]
    It turns out you are correct. I didn't withdraw my "huh?" comment, I think the editors clean up the comments section. I have corrected the article. Thank you for pointing this out!
    Jun 20 01:42 PM | 0 Likes Like |Link to Comment
  • BioTime Is Running Out Of Time - Short-Sell Idea [View article]
    15% vs. 35%, like everyone else. it matters but it doesn't if you hit the right IRRs.
    Apr 11 09:47 PM | 0 Likes Like |Link to Comment
  • BioTime Is Running Out Of Time - Short-Sell Idea [View article]
    i like GENT
    Apr 11 09:46 PM | 0 Likes Like |Link to Comment
COMMENTS STATS
350 Comments
69 Likes